Answer
Sep 01, 2026 - 11:29 AM
Litfulo (ritlecitinib) is an FDA-approved medication for treating severe alopecia areata, an autoimmune form of hair loss. Clinical trials have shown that Litfulo can be effective in promoting hair regrowth in some patients with this condition. However, its effectiveness may vary, and it is not approved for other types of hair loss.
